Chris Calise - 23 Aug 2023 Form 4 Insider Report for Coeptis Therapeutics Holdings, Inc. (COEP)

Role
Director
Signature
/s/ Christopher Calise
Issuer symbol
COEP
Transactions as of
23 Aug 2023
Net transactions value
+$10,879
Form type
4
Filing time
31 Aug 2023, 17:01:06 UTC
Previous filing
31 Jan 2023
Next filing
06 Mar 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction COEP Common Stock Purchase $8,460 +9,000 +0.62% $0.9400 1,462,315 23 Aug 2023 Direct F1
transaction COEP Common Stock Purchase $2,419 +2,582 +0.18% $0.9367 1,464,897 23 Aug 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes (i) 942,117 shares of common stock that are issuable under currently exercisable options and (ii) 7,500 shares of common stock that are issuable upon exercise of options that will become exercisable. Does not include 22,500 shares of common stock that are issuable upon exercise of options that are not currently exercisable and will not become exercisable in the next 60 days.